Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Varicella-Zoster Virus Disease in Patients With Human Immunodeficiency Virus Infection

Varicella-Zoster Virus Disease in Patients With Human Immunodeficiency Virus Infection Abstract Contact with varicella-zoster virus (VZV) is nearly universal in the United States, manifesting disease as varicella (primary infection) and herpes zoster (secondary or reactivated infection). Greater than 90% of adults in the United States show serologic evidence of previous VZV exposure. Prior to the acquired immunodeficiency syndrome (AIDS), there were an estimated three million cases of varicella and 1.5 million cases of zoster occurring annually in the United States. In 1983, VZV disease was first recognized in the context of infection with the human immunodeficiency virus (HIV). Since that time, there have been many reports on the occurrence and clinical manifestations of herpes zoster in HIV-infected patients and, more recently, the occurrence of primary varicella in such patients. In this issue of the Archives,1-3 three reports describe various aspects of VZV disease in the context of HIV infection. Prior to AIDS, the annual incidence of herpes zoster in the general population was about References 1. Perronne C, Lazanas M, Leport C, et al. Varicella in patients infected with the human immunodeficiency virus . Arch Dermatol. 1990;126:1033-1036.Crossref 2. Disler RS, Dover JS. Chronic localized herpes zoster in AIDS . Arch Dermatol. 1990;126:1105-1106.Crossref 3. Hoppenjans WB, Bibler MR, Orme RL, Solinger AM. Prolonged cutaneous herpes zoster in AIDS . Arch Dermatol. 1990;126:1048-1050.Crossref 4. Friedman-Kien AE, Lafleur FL, Gendler E, et al. Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals . J Am Acad Dermatol. 1986;14:1023-1028.Crossref 5. Colebunders R, Mann JM, Francis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection . J Infect Dis. 1988;157:314-318.Crossref 6. Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster . Lancet. 1987;1:728-731.Crossref 7. Cohen PR, Beltrani VP, Grossman ME. Disseminated herpes zoster in patients with human immunodeficiency virus infection . Am J Med. 1988;84:1076-1080.Crossref 8. Jura E, Chadwick EG, Josephs SH, et al. Varicella-zoster virus infection in children infected with human immunodeficiency virus . Pediatr Infect Dis. 1989;8:586-590.Crossref 9. Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ. Growth inhibition by acycloguanosine of herpes viruses isolated from human infections . Antimicrob Agents Chemother. 1979;15:642-645.Crossref 10. Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster virus infection in severely immunocompromised patients . N Engl J Med. 1986;314:208-212.Crossref 11. Alessi E, Cusini M, Zerboni R, et al. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome . Arch Dermatol. 1988;124:1011-1012.Crossref 12. Pahwa S, Biron K, Lim W, et al. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS . JAMA. 1988;260:2879-2882.Crossref 13. Jacobson MA, Berger TG, Fikrig S. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS) . Ann Intern Med. 1990;112:187-191.Crossref 14. Erlich KS, Mills J, Chatis P, et al. Acyclovir-resistant herpes simplex virus infection in patients with the acquired immunodeficiency syndrome . N Engl J Med. 1989;320:293-300.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Varicella-Zoster Virus Disease in Patients With Human Immunodeficiency Virus Infection

Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/varicella-zoster-virus-disease-in-patients-with-human-immunodeficiency-wjniXqR24Q

References (18)

Publisher
American Medical Association
Copyright
Copyright © 1990 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1990.01670320110022
Publisher site
See Article on Publisher Site

Abstract

Abstract Contact with varicella-zoster virus (VZV) is nearly universal in the United States, manifesting disease as varicella (primary infection) and herpes zoster (secondary or reactivated infection). Greater than 90% of adults in the United States show serologic evidence of previous VZV exposure. Prior to the acquired immunodeficiency syndrome (AIDS), there were an estimated three million cases of varicella and 1.5 million cases of zoster occurring annually in the United States. In 1983, VZV disease was first recognized in the context of infection with the human immunodeficiency virus (HIV). Since that time, there have been many reports on the occurrence and clinical manifestations of herpes zoster in HIV-infected patients and, more recently, the occurrence of primary varicella in such patients. In this issue of the Archives,1-3 three reports describe various aspects of VZV disease in the context of HIV infection. Prior to AIDS, the annual incidence of herpes zoster in the general population was about References 1. Perronne C, Lazanas M, Leport C, et al. Varicella in patients infected with the human immunodeficiency virus . Arch Dermatol. 1990;126:1033-1036.Crossref 2. Disler RS, Dover JS. Chronic localized herpes zoster in AIDS . Arch Dermatol. 1990;126:1105-1106.Crossref 3. Hoppenjans WB, Bibler MR, Orme RL, Solinger AM. Prolonged cutaneous herpes zoster in AIDS . Arch Dermatol. 1990;126:1048-1050.Crossref 4. Friedman-Kien AE, Lafleur FL, Gendler E, et al. Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals . J Am Acad Dermatol. 1986;14:1023-1028.Crossref 5. Colebunders R, Mann JM, Francis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection . J Infect Dis. 1988;157:314-318.Crossref 6. Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster . Lancet. 1987;1:728-731.Crossref 7. Cohen PR, Beltrani VP, Grossman ME. Disseminated herpes zoster in patients with human immunodeficiency virus infection . Am J Med. 1988;84:1076-1080.Crossref 8. Jura E, Chadwick EG, Josephs SH, et al. Varicella-zoster virus infection in children infected with human immunodeficiency virus . Pediatr Infect Dis. 1989;8:586-590.Crossref 9. Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ. Growth inhibition by acycloguanosine of herpes viruses isolated from human infections . Antimicrob Agents Chemother. 1979;15:642-645.Crossref 10. Shepp DH, Dandliker PS, Meyers JD. Treatment of varicella-zoster virus infection in severely immunocompromised patients . N Engl J Med. 1986;314:208-212.Crossref 11. Alessi E, Cusini M, Zerboni R, et al. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome . Arch Dermatol. 1988;124:1011-1012.Crossref 12. Pahwa S, Biron K, Lim W, et al. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS . JAMA. 1988;260:2879-2882.Crossref 13. Jacobson MA, Berger TG, Fikrig S. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS) . Ann Intern Med. 1990;112:187-191.Crossref 14. Erlich KS, Mills J, Chatis P, et al. Acyclovir-resistant herpes simplex virus infection in patients with the acquired immunodeficiency syndrome . N Engl J Med. 1989;320:293-300.Crossref

Journal

Archives of Dermatology – American Medical Association

Published: Aug 1, 1990

There are no references for this article.